Philip McFarlane
Overview
Explore the profile of Philip McFarlane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
690
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rigatto C, Collister D, Granger-Vallee A, Girard L, Hingwala J, Karaboyas A, et al.
Can J Kidney Health Dis
. 2024 Apr;
11:20543581241238808.
PMID: 38680970
Purpose Of Review: Chronic kidney disease (CKD)-associated pruritus is a common, persistent, and distressing itch experienced by patients across the CKD spectrum. Although the disorder is associated with adverse outcomes...
2.
Cherney D, Bell A, Girard L, McFarlane P, Moist L, Nessim S, et al.
Can J Kidney Health Dis
. 2023 Feb;
10:20543581221150556.
PMID: 36726361
Purpose Of Review: Kidney disease is present in almost half of Canadian patients with type 2 diabetes (T2D), and it is also the most common first cardiorenal manifestation of T2D....
3.
Fitchett D, Leiter L, Lin P, Pickering J, Welsh R, Stone J, et al.
CJC Open
. 2020 Sep;
2(5):402-415.
PMID: 32995726
A recent acute coronary syndrome provides an opportunity to optimise secondary prevention strategies to reduce the risk of future cardiovascular events. This review provides an updated synopsis of current evidence-based...
4.
Glavinovic T, Kashani M, Al-Sahlawi M, Anderson E, Freeman M, Dacouris N, et al.
Perit Dial Int
. 2019 May;
39(5):437-446.
PMID: 31123070
Little evidence exists regarding optimal peritoneal dialysis (PD) access insertion pathways, benchmarking for patency targets, and definitions of access dysfunction.This quality improvement (QI) project evaluated patients with PD catheters inserted...
5.
Woo V, Connelly K, Lin P, McFarlane P
Curr Med Res Opin
. 2019 Feb;
35(7):1283-1295.
PMID: 30767677
Heart failure (HF) and chronic kidney disease (CKD) are responsible for substantial morbidity and mortality in individuals with type 2 diabetes (T2D). This review discusses the significance of these comorbidities...
6.
Soroka S, Alam A, Bevilacqua M, Girard L, Komenda P, Loertscher R, et al.
Can J Kidney Health Dis
. 2018 Oct;
5:2054358118801589.
PMID: 30345064
Purpose: The purpose of this article is to update the previously published consensus recommendations from March 2017 discussing the optimal management of adult patients with autosomal dominant polycystic kidney disease...
7.
McFarlane P, Cherney D, Gilbert R, Senior P
Can J Diabetes
. 2018 Apr;
42 Suppl 1:S201-S209.
PMID: 29650098
No abstract available.
8.
Soroka S, Alam A, Bevilacqua M, Girard L, Komenda P, Loertscher R, et al.
Can J Kidney Health Dis
. 2017 Mar;
4:2054358117695784.
PMID: 28321325
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited renal disorder worldwide. The disease is characterized by renal cysts and progressive renal failure due to progressive enlargement of...
9.
Fitchett D, Goodman S, Leiter L, Lin P, Welsh R, Stone J, et al.
Can J Cardiol
. 2016 Jun;
32(7 Suppl):S15-34.
PMID: 27342696
In the past 3 decades, a better understanding of the pathophysiology of cardiovascular disease has resulted in innovations in the treatment and prevention of its clinical manifestations such as death,...
10.
Davies E, Matza L, Worth G, Feeny D, Kostelec J, Soroka S, et al.
Health Qual Life Outcomes
. 2015 Jul;
13:90.
PMID: 26122041
Background: Patients with chronic kidney disease (CKD) and secondary hyperparathyroidism (SHPT) who require dialysis are at increased risk for cardiovascular events and bone fractures. To assist in economic evaluations, this...